Neutralizing antibodies hamper IFNβ bioactivity and treatment effect on MRI in patients with MS
- 14 November 2006
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (9) , 1681-1683
Abstract
We measured neutralizing antibodies (NABs) and the in vivo biologic response to interferon-β on neopterin and β2-microglobulin blood levels. All NAB-negative patients had an in vivo biologic response (full or partial), whereas all high-level positive patients had no response. High-level NAB patients had more MRI activity than NAB-negative patients (p = 0.031). Patients with a full response had less MRI activity than patients without biologic response (p = 0.032).Keywords
This publication has 10 references indexed in Scilit:
- Guidelines on use of anti‐IFN‐β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN‐β antibodies in multiple sclerosisEuropean Journal of Neurology, 2005
- The importance of measuring IFNβ bioactivity: Monitoring in MS patients and the effect of anti-IFNβ antibodiesJournal of Neuroimmunology, 2005
- Anti-IFN BAb and NAb antibodiesNeurology, 2003
- Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosisThe Lancet, 2003
- A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFNJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patientsNeurology, 2003
- Neuronal Classes in the Isocortex of a Monotreme, the Australian Echidna (Tachyglossus aculeatus)Brain, Behavior and Evolution, 2003
- Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patientsNeurology, 2001
- The Neutralization of Interferons by Antibody. II. Neutralizing Antibody Unitage and Its Relationship to Bioassay Sensitivity: The Tenfold Reduction UnitJournal of Interferon & Cytokine Research, 2001
- Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosisNeurology, 1998